165 related articles for article (PubMed ID: 15500242)
1. [Identification of tumor antigens: strategies and perspectives].
Jäger D; Zippelius A; Knuth A
Praxis (Bern 1994); 2004 Sep; 93(39):1584-8. PubMed ID: 15500242
[TBL] [Abstract][Full Text] [Related]
2. [Identification of tumor antigens: strategies and perspectives].
Zippelius A; Knights A; Tinguely M; Jäger D; Renner C; Knuth A
Dtsch Med Wochenschr; 2006 Aug; 131(33):1809-12. PubMed ID: 16902905
[No Abstract] [Full Text] [Related]
3. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
4. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
[TBL] [Abstract][Full Text] [Related]
5. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel prostate cancer-associated tumor antigen.
Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
[TBL] [Abstract][Full Text] [Related]
8. [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
Gaugler B; Olive D
Pathol Biol (Paris); 1998 Dec; 46(10):771-8. PubMed ID: 9922993
[TBL] [Abstract][Full Text] [Related]
9. Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).
Matsuzaki Y; Hashimoto S; Fujita T; Suzuki T; Sakurai T; Matsushima K; Kawakami Y
J Immunother; 2005; 28(1):10-9. PubMed ID: 15614040
[TBL] [Abstract][Full Text] [Related]
10. Tumor antigens and tumor vaccines: peptides as immunogens.
Slingluff CL
Semin Surg Oncol; 1996; 12(6):446-53. PubMed ID: 8914209
[TBL] [Abstract][Full Text] [Related]
11. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].
Prikler L; Scandella E; Men Y; Engeler DS; Diener PA; Gillessen S; Ludewig B; Schmid HP
Aktuelle Urol; 2004 Aug; 35(4):326-30. PubMed ID: 15459874
[TBL] [Abstract][Full Text] [Related]
12. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
13. Mitofilin and titin as target antigens in melanoma-associated retinopathy.
Pföhler C; Preuss KD; Tilgen W; Stark A; Regitz E; Fadle N; Pfreundschuh M
Int J Cancer; 2007 Feb; 120(4):788-95. PubMed ID: 17131336
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.
Aguilar LK; Guzik BW; Aguilar-Cordova E
J Cell Biochem; 2011 Aug; 112(8):1969-77. PubMed ID: 21465529
[TBL] [Abstract][Full Text] [Related]
15. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
16. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.
Hartmann TB; Bazhin AV; Schadendorf D; Eichmüller SB
Int J Cancer; 2005 Mar; 114(1):88-93. PubMed ID: 15523688
[TBL] [Abstract][Full Text] [Related]
17. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.
Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M
Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
Valmori D; Dutoit V; Ayyoub M; Rimoldi D; Guillaume P; Liénard D; Lejeune F; Cerottini JC; Romero P; Speiser DE
Cancer Immun; 2003 Oct; 3():15. PubMed ID: 14580186
[TBL] [Abstract][Full Text] [Related]
19. Vaccines against advanced melanoma.
Blanchard T; Srivastava PK; Duan F
Clin Dermatol; 2013; 31(2):179-90. PubMed ID: 23438381
[TBL] [Abstract][Full Text] [Related]
20. Immunomic analysis of human sarcoma.
Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
